SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017500
Filing Date
2024-06-18
Accepted
2024-06-18 19:44:21
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 form4-06182024_110617.html 4  
1 form4-06182024_110617.xml 4 5545
  Complete submission text file 0001415889-24-017500.txt   7068
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IGM BIOSCIENCES, INC. 325 E. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address
Takimoto Chris H (Reporting) CIK: 0001743780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 241053635